{"id":44464,"date":"2022-05-30T16:01:36","date_gmt":"2022-05-30T14:01:36","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-transdermal-skin-patches-market-report-2022-2031-featuring-major-players-mylan-pharmaceuticals-hisamitsu-pharmaceutical-novartis-johnson-johnson-teikoku-pharma-researchandmarkets-com\/"},"modified":"2022-05-30T16:01:36","modified_gmt":"2022-05-30T14:01:36","slug":"global-transdermal-skin-patches-market-report-2022-2031-featuring-major-players-mylan-pharmaceuticals-hisamitsu-pharmaceutical-novartis-johnson-johnson-teikoku-pharma-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-transdermal-skin-patches-market-report-2022-2031-featuring-major-players-mylan-pharmaceuticals-hisamitsu-pharmaceutical-novartis-johnson-johnson-teikoku-pharma-researchandmarkets-com\/","title":{"rendered":"Global Transdermal Skin Patches Market Report 2022-2031 Featuring Major Players &#8211; Mylan Pharmaceuticals, Hisamitsu Pharmaceutical, Novartis, Johnson &amp; Johnson, Teikoku Pharma &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5553687\/transdermal-skin-patches-global-market-report?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=9c9t3p&amp;utm_campaign=1706747+-+Global+Transdermal+Skin+Patches+Market+Report+2022-2031+Featuring+Major+Players+-+Mylan+Pharmaceuticals%2C+Hisamitsu+Pharmaceutical%2C+Novartis%2C+Johnson+%26+Johnson%2C+Teikoku+Pharma&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Transdermal Skin Patches Global Market Report 2022: By Product, By Type, By Application&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220530005262\/en\/1470392\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220530005262\/en\/1470392\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe global transdermal skin patches market is expected to grow from $6.80 billion in 2021 to $7.10 billion in 2022 at a compound annual growth rate (CAGR) of 4.5%. The market is expected to reach $8.13 billion in 2026 at a CAGR of 3.4%.\n<\/p>\n<p>\nThe transdermal skin patches market consists of sales of transdermal skin patches products and related services used to provide medicine to the human body through patches. Transdermal skin patches involve the use of adhesive patches made up of polymers that contains drugs. The drugs from these patches are absorbed into the body and eventually into the blood stream eliminating the drug delivery through pill, or injections.\n<\/p>\n<p>\nThe main types of transdermal skin patches are fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch and others. Nicotine transdermal skin patches are used to assist people in quitting smoking. They provide a source of nicotine through skin of human body that helps to alleviate the withdrawal symptoms associated with quitting smoking. That various products used involve matrix, drug in adhesive, reservoir and vapor that are utilized for pain relief, nicotine cessation, hormone replacement therapy, neurological disorders, cardiovascular disorders and others.\n<\/p>\n<p>\nNorth America was the largest region in the transdermal skin patches market in 2021. Middle East is expected to be the fargest growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.\n<\/p>\n<p>\nThe advances in the modern technologies contribute to the growth of transdermal skin patches market. Advances in modern technologies increase the number of drugs being delivered transdermally including small molecule hydrophobic drugs, hydrophilic drugs, and macromolecules.\n<\/p>\n<p>\nThe new technological advances add to the increased efficiency and increased use of transdermal drug delivery systems (TDDS) thus, increasing the popularity and demand for TDDS. The advances in technologies are expected to increase the demand for transdermal patches owing to its benefits thereby driving the growth of the market.\n<\/p>\n<p>\nStringent regulatory approval by the government regulatory bodies is a key factor hindering the growth of the transdermal skin patches market. The regulatory authority enforces the laws regulating biologics, medications, and medical devices, which can have potential side effects for customers. The whole process consumes time and may result in delay for the launch of TDDS into the market losing the first-mover advantage thus restraining the growth of the transdermal skin patch market.\n<\/p>\n<p>\nMajor companies in the market are increasingly opting for acquisitions and collaborations to enhance and expand their footprint for the growth of the transdermal skin patches market. The strategic merger and acquisition and collaboration followed by the players in the transdermal skin patches market allows the companies to take technological advantage by acquiring the technology which allows them to get ahead in the competition. Thus, companies operating in the transdermal skin patch market are following the strategic collaborations and acquisitions to have a competitive edge.\n<\/p>\n<p>\n<strong>Major players in the transdermal skin patches market are<\/strong>\n<\/p>\n<ul>\n<li>\nMylan Pharmaceuticals inc.\n<\/li>\n<li>\nHisamitsu Pharmaceutical\n<\/li>\n<li>\nNovartis\n<\/li>\n<li>\nJohnson &amp; Johnson\n<\/li>\n<li>\nTeikoku Pharma\n<\/li>\n<li>\nMylan\n<\/li>\n<li>\nActavis\n<\/li>\n<li>\nMundipharma\n<\/li>\n<li>\nHenan Lingrui Pharmaceutical\n<\/li>\n<li>\nChangzhou Siyao\n<\/li>\n<li>\nRfl Pharmaceutical\n<\/li>\n<li>\nTeva\n<\/li>\n<li>\nProSolus inc.\n<\/li>\n<li>\nMedipatch inc.\n<\/li>\n<li>\nAdhexPharma\n<\/li>\n<li>\nMedherant Limited\n<\/li>\n<li>\nNitto Denko\n<\/li>\n<li>\nNoven Pharmaceuticals\n<\/li>\n<li>\n3M Pharmaceuticals\n<\/li>\n<li>\nAccrux Ltd.\n<\/li>\n<li>\nAccess Pharmaceuticals inc.\n<\/li>\n<li>\nLuye Pharma Group Ltd.\n<\/li>\n<li>\nPurdue Pharma L.P.\n<\/li>\n<li>\nAbbott Laboratories\n<\/li>\n<li>\nAneva Drug Delivery Systems\n<\/li>\n<li>\nAllergan plc.\n<\/li>\n<li>\nCorium International inc.\n<\/li>\n<li>\nImmune Pharmaceuticals\n<\/li>\n<li>\nHercon Pharmaceuticals\n<\/li>\n<li>\nPocono\n<\/li>\n<li>\nDURECT Corporation\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>1. Executive Summary<\/strong>\n<\/p>\n<p>\n<strong>2. Transdermal Skin Patches Market Characteristics<\/strong>\n<\/p>\n<p>\n<strong>3. Transdermal Skin Patches Market Trends And Strategies<\/strong>\n<\/p>\n<p>\n<strong>4. Impact Of COVID-19 On Transdermal Skin Patches<\/strong>\n<\/p>\n<p>\n<strong>5. Transdermal Skin Patches Market Size And Growth<\/strong>\n<\/p>\n<p>\n5.1. Global Transdermal Skin Patches Historic Market, 2016-2021, $ Billion\n<\/p>\n<p>\n5.1.1. Drivers Of The Market\n<\/p>\n<p>\n5.1.2. Restraints On The Market\n<\/p>\n<p>\n5.2. Global Transdermal Skin Patches Forecast Market, 2021-2026F, 2031F, $ Billion\n<\/p>\n<p>\n5.2.1. Drivers Of The Market\n<\/p>\n<p>\n5.2.2. Restraints On the Market\n<\/p>\n<p>\n<strong>6. Transdermal Skin Patches Market Segmentation<\/strong>\n<\/p>\n<p>\n6.1. Global Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion\n<\/p>\n<ul>\n<li>\nMatrix\n<\/li>\n<li>\nDrug In Adhesive\n<\/li>\n<li>\nReservoir\n<\/li>\n<li>\nVapor\n<\/li>\n<\/ul>\n<p>\n6.2. Global Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion\n<\/p>\n<ul>\n<li>\nFentanyl Transdermal Patch\n<\/li>\n<li>\nNicotine Transdermal Patch\n<\/li>\n<li>\nBuprenorphine Transdermal Patch\n<\/li>\n<li>\nClonidine Transdermal Patch\n<\/li>\n<li>\nOxybutynin Transdermal Patch\n<\/li>\n<li>\nOthers\n<\/li>\n<\/ul>\n<p>\n6.3. Global Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion\n<\/p>\n<ul>\n<li>\nPain Relief\n<\/li>\n<li>\nNicotine Cessation\n<\/li>\n<li>\nHormone Replacement Therapy\n<\/li>\n<li>\nNeurological Disorders\n<\/li>\n<li>\nCardiovascular Disorders\n<\/li>\n<li>\nOthers\n<\/li>\n<\/ul>\n<p>\n<strong>7. Transdermal Skin Patches Market Regional And Country Analysis<\/strong>\n<\/p>\n<p>\n7.1. Global Transdermal Skin Patches Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion\n<\/p>\n<p>\n7.2. Global Transdermal Skin Patches Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion\n<\/p>\n<p>\n<strong>8. Asia-Pacific Transdermal Skin Patches Market<\/strong>\n<\/p>\n<p>\n8.1. Asia-Pacific Transdermal Skin Patches Market Overview\n<\/p>\n<ul>\n<li>\nRegion Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies\n<\/li>\n<\/ul>\n<p>\n8.2. Asia-Pacific Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion\n<\/p>\n<p>\n8.3. Asia-Pacific Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion\n<\/p>\n<p>\n<strong>9. China Transdermal Skin Patches Market<\/strong>\n<\/p>\n<p>\n<strong>10. India Transdermal Skin Patches Market<\/strong>\n<\/p>\n<p>\n<strong>11. Japan Transdermal Skin Patches Market<\/strong>\n<\/p>\n<p>\n<strong>12. Australia Transdermal Skin Patches Market<\/strong>\n<\/p>\n<p>\n<strong>13. Indonesia Transdermal Skin Patches Market<\/strong>\n<\/p>\n<p>\n<strong>14. South Korea Transdermal Skin Patches Market<\/strong>\n<\/p>\n<p>\n<strong>15. Western Europe Transdermal Skin Patches Market<\/strong>\n<\/p>\n<p>\n<strong>16. UK Transdermal Skin Patches Market<\/strong>\n<\/p>\n<p>\n<strong>17. Germany Transdermal Skin Patches Market<\/strong>\n<\/p>\n<p>\n<strong>18. France Transdermal Skin Patches Market<\/strong>\n<\/p>\n<p>\n<strong>19. Eastern Europe Transdermal Skin Patches Market<\/strong>\n<\/p>\n<p>\n<strong>20. Russia Transdermal Skin Patches Market<\/strong>\n<\/p>\n<p>\n<strong>21. North America Transdermal Skin Patches Market<\/strong>\n<\/p>\n<p>\n<strong>22. USA Transdermal Skin Patches Market<\/strong>\n<\/p>\n<p>\n<strong>23. South America Transdermal Skin Patches Market<\/strong>\n<\/p>\n<p>\n<strong>24. Brazil Transdermal Skin Patches Market<\/strong>\n<\/p>\n<p>\n<strong>25. Middle East Transdermal Skin Patches Market<\/strong>\n<\/p>\n<p>\n<strong>26. Africa Transdermal Skin Patches Market<\/strong>\n<\/p>\n<p>\n<strong>27. Transdermal Skin Patches Market Competitive Landscape And Company Profiles<\/strong>\n<\/p>\n<p>\n27.1. Transdermal Skin Patches Market Competitive Landscape\n<\/p>\n<p>\n27.2. Transdermal Skin Patches Market Company Profiles\n<\/p>\n<p>\n27.2.1. Mylan Pharmaceuticals Inc\n<\/p>\n<p>\n27.2.2. Hisamitsu Pharmaceutical\n<\/p>\n<p>\n27.2.3. Novartis\n<\/p>\n<p>\n27.2.4. Johnson &amp; Johnson\n<\/p>\n<p>\n27.2.5. Teikoku Pharma\n<\/p>\n<p>\n<strong>28. Transdermal Skin Patches Pipeline Analysis<\/strong>\n<\/p>\n<p>\n<strong>29. Key Mergers And Acquisitions In The Transdermal Skin Patches Market<\/strong>\n<\/p>\n<p>\n<strong>30. Transdermal Skin Patches Market Future Outlook and Potential Analysis<\/strong>\n<\/p>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5553687\/transdermal-skin-patches-global-market-report?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=9c9t3p&amp;utm_campaign=1706747+-+Global+Transdermal+Skin+Patches+Market+Report+2022-2031+Featuring+Major+Players+-+Mylan+Pharmaceuticals%2C+Hisamitsu+Pharmaceutical%2C+Novartis%2C+Johnson+%26+Johnson%2C+Teikoku+Pharma&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/xxgevh<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;a&#x69;l&#x74;&#111;&#x3a;&#112;r&#x65;s&#x73;&#64;&#x72;&#101;&#x73;&#101;a&#x72;c&#x68;&#97;&#x6e;&#100;&#x6d;&#x61;r&#x6b;e&#x74;&#115;&#x2e;&#99;o&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">pre&#115;&#115;&#64;&#114;&#x65;&#x73;&#x65;&#x61;&#x72;&#x63;&#x68;and&#109;&#97;&#114;&#107;&#101;&#x74;&#x73;&#x2e;&#x63;&#x6f;&#x6d;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Transdermal Skin Patches Global Market Report 2022: By Product, By Type, By Application&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global transdermal skin patches market is expected to grow from $6.80 billion in 2021 to $7.10 billion in 2022 at a compound annual growth rate (CAGR) of 4.5%. The market is expected &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-transdermal-skin-patches-market-report-2022-2031-featuring-major-players-mylan-pharmaceuticals-hisamitsu-pharmaceutical-novartis-johnson-johnson-teikoku-pharma-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44464","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Transdermal Skin Patches Market Report 2022-2031 Featuring Major Players - Mylan Pharmaceuticals, Hisamitsu Pharmaceutical, Novartis, Johnson &amp; Johnson, Teikoku Pharma - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-transdermal-skin-patches-market-report-2022-2031-featuring-major-players-mylan-pharmaceuticals-hisamitsu-pharmaceutical-novartis-johnson-johnson-teikoku-pharma-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Transdermal Skin Patches Market Report 2022-2031 Featuring Major Players - Mylan Pharmaceuticals, Hisamitsu Pharmaceutical, Novartis, Johnson &amp; Johnson, Teikoku Pharma - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Transdermal Skin Patches Global Market Report 2022: By Product, By Type, By Application&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global transdermal skin patches market is expected to grow from $6.80 billion in 2021 to $7.10 billion in 2022 at a compound annual growth rate (CAGR) of 4.5%. The market is expected ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-transdermal-skin-patches-market-report-2022-2031-featuring-major-players-mylan-pharmaceuticals-hisamitsu-pharmaceutical-novartis-johnson-johnson-teikoku-pharma-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-30T14:01:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220530005262\/en\/1470392\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-transdermal-skin-patches-market-report-2022-2031-featuring-major-players-mylan-pharmaceuticals-hisamitsu-pharmaceutical-novartis-johnson-johnson-teikoku-pharma-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-transdermal-skin-patches-market-report-2022-2031-featuring-major-players-mylan-pharmaceuticals-hisamitsu-pharmaceutical-novartis-johnson-johnson-teikoku-pharma-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Transdermal Skin Patches Market Report 2022-2031 Featuring Major Players &#8211; Mylan Pharmaceuticals, Hisamitsu Pharmaceutical, Novartis, Johnson &amp; Johnson, Teikoku Pharma &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-05-30T14:01:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-transdermal-skin-patches-market-report-2022-2031-featuring-major-players-mylan-pharmaceuticals-hisamitsu-pharmaceutical-novartis-johnson-johnson-teikoku-pharma-researchandmarkets-com\\\/\"},\"wordCount\":1068,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-transdermal-skin-patches-market-report-2022-2031-featuring-major-players-mylan-pharmaceuticals-hisamitsu-pharmaceutical-novartis-johnson-johnson-teikoku-pharma-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220530005262\\\/en\\\/1470392\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-transdermal-skin-patches-market-report-2022-2031-featuring-major-players-mylan-pharmaceuticals-hisamitsu-pharmaceutical-novartis-johnson-johnson-teikoku-pharma-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-transdermal-skin-patches-market-report-2022-2031-featuring-major-players-mylan-pharmaceuticals-hisamitsu-pharmaceutical-novartis-johnson-johnson-teikoku-pharma-researchandmarkets-com\\\/\",\"name\":\"Global Transdermal Skin Patches Market Report 2022-2031 Featuring Major Players - Mylan Pharmaceuticals, Hisamitsu Pharmaceutical, Novartis, Johnson &amp; Johnson, Teikoku Pharma - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-transdermal-skin-patches-market-report-2022-2031-featuring-major-players-mylan-pharmaceuticals-hisamitsu-pharmaceutical-novartis-johnson-johnson-teikoku-pharma-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-transdermal-skin-patches-market-report-2022-2031-featuring-major-players-mylan-pharmaceuticals-hisamitsu-pharmaceutical-novartis-johnson-johnson-teikoku-pharma-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220530005262\\\/en\\\/1470392\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-05-30T14:01:36+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-transdermal-skin-patches-market-report-2022-2031-featuring-major-players-mylan-pharmaceuticals-hisamitsu-pharmaceutical-novartis-johnson-johnson-teikoku-pharma-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-transdermal-skin-patches-market-report-2022-2031-featuring-major-players-mylan-pharmaceuticals-hisamitsu-pharmaceutical-novartis-johnson-johnson-teikoku-pharma-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-transdermal-skin-patches-market-report-2022-2031-featuring-major-players-mylan-pharmaceuticals-hisamitsu-pharmaceutical-novartis-johnson-johnson-teikoku-pharma-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220530005262\\\/en\\\/1470392\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220530005262\\\/en\\\/1470392\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-transdermal-skin-patches-market-report-2022-2031-featuring-major-players-mylan-pharmaceuticals-hisamitsu-pharmaceutical-novartis-johnson-johnson-teikoku-pharma-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Transdermal Skin Patches Market Report 2022-2031 Featuring Major Players &#8211; Mylan Pharmaceuticals, Hisamitsu Pharmaceutical, Novartis, Johnson &amp; Johnson, Teikoku Pharma &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Transdermal Skin Patches Market Report 2022-2031 Featuring Major Players - Mylan Pharmaceuticals, Hisamitsu Pharmaceutical, Novartis, Johnson &amp; Johnson, Teikoku Pharma - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-transdermal-skin-patches-market-report-2022-2031-featuring-major-players-mylan-pharmaceuticals-hisamitsu-pharmaceutical-novartis-johnson-johnson-teikoku-pharma-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Transdermal Skin Patches Market Report 2022-2031 Featuring Major Players - Mylan Pharmaceuticals, Hisamitsu Pharmaceutical, Novartis, Johnson &amp; Johnson, Teikoku Pharma - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Transdermal Skin Patches Global Market Report 2022: By Product, By Type, By Application&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global transdermal skin patches market is expected to grow from $6.80 billion in 2021 to $7.10 billion in 2022 at a compound annual growth rate (CAGR) of 4.5%. The market is expected ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-transdermal-skin-patches-market-report-2022-2031-featuring-major-players-mylan-pharmaceuticals-hisamitsu-pharmaceutical-novartis-johnson-johnson-teikoku-pharma-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-05-30T14:01:36+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220530005262\/en\/1470392\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-transdermal-skin-patches-market-report-2022-2031-featuring-major-players-mylan-pharmaceuticals-hisamitsu-pharmaceutical-novartis-johnson-johnson-teikoku-pharma-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-transdermal-skin-patches-market-report-2022-2031-featuring-major-players-mylan-pharmaceuticals-hisamitsu-pharmaceutical-novartis-johnson-johnson-teikoku-pharma-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Transdermal Skin Patches Market Report 2022-2031 Featuring Major Players &#8211; Mylan Pharmaceuticals, Hisamitsu Pharmaceutical, Novartis, Johnson &amp; Johnson, Teikoku Pharma &#8211; ResearchAndMarkets.com","datePublished":"2022-05-30T14:01:36+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-transdermal-skin-patches-market-report-2022-2031-featuring-major-players-mylan-pharmaceuticals-hisamitsu-pharmaceutical-novartis-johnson-johnson-teikoku-pharma-researchandmarkets-com\/"},"wordCount":1068,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-transdermal-skin-patches-market-report-2022-2031-featuring-major-players-mylan-pharmaceuticals-hisamitsu-pharmaceutical-novartis-johnson-johnson-teikoku-pharma-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220530005262\/en\/1470392\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-transdermal-skin-patches-market-report-2022-2031-featuring-major-players-mylan-pharmaceuticals-hisamitsu-pharmaceutical-novartis-johnson-johnson-teikoku-pharma-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-transdermal-skin-patches-market-report-2022-2031-featuring-major-players-mylan-pharmaceuticals-hisamitsu-pharmaceutical-novartis-johnson-johnson-teikoku-pharma-researchandmarkets-com\/","name":"Global Transdermal Skin Patches Market Report 2022-2031 Featuring Major Players - Mylan Pharmaceuticals, Hisamitsu Pharmaceutical, Novartis, Johnson &amp; Johnson, Teikoku Pharma - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-transdermal-skin-patches-market-report-2022-2031-featuring-major-players-mylan-pharmaceuticals-hisamitsu-pharmaceutical-novartis-johnson-johnson-teikoku-pharma-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-transdermal-skin-patches-market-report-2022-2031-featuring-major-players-mylan-pharmaceuticals-hisamitsu-pharmaceutical-novartis-johnson-johnson-teikoku-pharma-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220530005262\/en\/1470392\/21\/logo.jpg","datePublished":"2022-05-30T14:01:36+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-transdermal-skin-patches-market-report-2022-2031-featuring-major-players-mylan-pharmaceuticals-hisamitsu-pharmaceutical-novartis-johnson-johnson-teikoku-pharma-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-transdermal-skin-patches-market-report-2022-2031-featuring-major-players-mylan-pharmaceuticals-hisamitsu-pharmaceutical-novartis-johnson-johnson-teikoku-pharma-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-transdermal-skin-patches-market-report-2022-2031-featuring-major-players-mylan-pharmaceuticals-hisamitsu-pharmaceutical-novartis-johnson-johnson-teikoku-pharma-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220530005262\/en\/1470392\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220530005262\/en\/1470392\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-transdermal-skin-patches-market-report-2022-2031-featuring-major-players-mylan-pharmaceuticals-hisamitsu-pharmaceutical-novartis-johnson-johnson-teikoku-pharma-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Transdermal Skin Patches Market Report 2022-2031 Featuring Major Players &#8211; Mylan Pharmaceuticals, Hisamitsu Pharmaceutical, Novartis, Johnson &amp; Johnson, Teikoku Pharma &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44464","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44464"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44464\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44464"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44464"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44464"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}